Compass Therapeutics Inc [CMPX] stock is trading at $1.90, up 3.26%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CMPX shares have gain 11.11% over the last week, with a monthly amount glided 20.25%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Compass Therapeutics Inc [NASDAQ: CMPX] stock has seen the most recent analyst activity on September 16, 2024, when Ladenburg Thalmann upgraded its rating to a Buy but kept the price target unchanged to $5 for it. Previously, Jefferies started tracking the stock with Buy rating on January 31, 2023, and set its price target to $8. On January 27, 2023, Stifel initiated with a Buy rating and assigned a price target of $9 on the stock. Ladenburg Thalmann initiated its recommendation with a Buy and recommended $7 as its price target on March 15, 2022. B. Riley Securities started tracking with a Buy rating for this stock on January 19, 2022, and assigned it a price target of $10. In a note dated December 22, 2021, Raymond James initiated an Outperform rating and provided a target price of $5 on this stock.
Compass Therapeutics Inc [CMPX] stock has fluctuated between $0.76 and $2.34 over the past year. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Compass Therapeutics Inc [NASDAQ: CMPX] shares were valued at $1.90 at the most recent close of the market. An investor can expect a potential return of 163.16% based on the average CMPX price forecast.
Analyzing the CMPX fundamentals
Gross Profit Margin for this corporation currently stands at 0.34% with Operating Profit Margin at -18.79%, Pretax Profit Margin comes in at -15.98%, and Net Profit Margin reading is -15.98%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.29 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8167 points at the first support level, and at 1.7333 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9667, and for the 2nd resistance point, it is at 2.0333.
Ratios To Look Out For
For context, Compass Therapeutics Inc’s Current Ratio is 16.15. In addition, the Quick Ratio stands at 16.15 and the Cash Ratio stands at 6.08. Considering the valuation of this stock, the price to sales ratio is 307.55, the price to book ratio is 1.79.
